Jointown Pharmaceutical Group Co Ltd
SSE:600998

Watchlist Manager
Jointown Pharmaceutical Group Co Ltd Logo
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Watchlist
Price: 5.11 CNY 0.59% Market Closed
Market Cap: 25.8B CNY
Section:
 

Relative Value

The Relative Value of one Jointown Pharmaceutical Group Co Ltd stock under the Base Case scenario is 24.17 CNY. Compared to the current market price of 5.11 CNY, Jointown Pharmaceutical Group Co Ltd is Undervalued by 79%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
24.17 CNY
Undervaluation 79%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
63
vs Industry
89
Median 3Y
0.2
Median 5Y
0.2
Industry
2.3
Forward
0.2
More Details
9.2
P/E
P/E
Price to Earnings
9.2
vs History
50
vs Industry
37
Median 3Y
13
Median 5Y
9.2
Industry
22.5
Forward
9.8
More Details
7.5
P/OCF
P/OCF
Price to OCF
7.5
vs History
52
vs Industry
20
Median 3Y
8.1
Median 5Y
7.5
Industry
14.5
More Details
13.5
P/FCFE
P/FCFE
Price to FCFE
13.5
vs History
38
vs Industry
35
Median 3Y
13.2
Median 5Y
9.6
Industry
21.5
More Details
0.9
P/B
P/B
Price to Book Value
0.9
vs History
61
vs Industry
64
Median 3Y
1
Median 5Y
0.9
Industry
2.2
More Details
0.3
EV/S
EV/S
Enterprise Value to Sales
0.3
vs History
71
vs Industry
84
Median 3Y
0.3
Median 5Y
0.3
Industry
2.6
Forward
0.2
More Details
3.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.5
vs History
71
vs Industry
48
Median 3Y
3.8
Median 5Y
4.1
Industry
5.2
More Details
11.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.5
vs History
47
vs Industry
28
Median 3Y
11.5
Median 5Y
11.3
Industry
11.9
Forward
8.5
More Details
11.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
11.5
vs History
47
vs Industry
34
Median 3Y
11.5
Median 5Y
11.3
Industry
16.9
Forward
9.3
More Details
11.8
EV/OCF
EV/OCF
Enterprise Value to OCF
11.8
vs History
57
vs Industry
9
Median 3Y
12.4
Median 5Y
12
Industry
14.7
More Details
19.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
19.7
vs History
52
vs Industry
3
Median 3Y
18.4
Median 5Y
20.1
Industry
18.7
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
57
vs Industry
67
Median 3Y
0.7
Median 5Y
0.7
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Jointown Pharmaceutical Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Jointown Pharmaceutical Group Co Ltd
SSE:600998
25.8B CNY 0.2 9.2 11.5 11.5
US
Mckesson Corp
NYSE:MCK
100.3B USD 0.3 24.9 17.5 19.7
US
Cencora Inc
NYSE:COR
65.9B USD 0.2 42.4 14.3 18.4
US
Amerisourcebergen Corp
LSE:0HF3
66B USD 0.2 42.5 14.4 18.5
US
Cardinal Health Inc
NYSE:CAH
47.3B USD 0.2 29.7 14.6 19.2
AU
Sigma Healthcare Ltd
ASX:SIG
32.8B AUD 5.5 61.9 46.8 46.8
CN
Huadong Medicine Co Ltd
SZSE:000963
73.9B CNY 1.7 20 15.5 15.5
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
66.4B CNY 0.2 11.8 15.6 15.6
US
Henry Schein Inc
NASDAQ:HSIC
8.7B USD 0.7 22.3 10.9 15.2
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
CN
Sinopharm Group Co Ltd
HKEX:1099
64.2B HKD 0.1 8.6 1.6 2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 301,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.